(Q37929194)

25 August 2017

1 reference

title

APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens (English)

1 reference

25 August 2017

main subject

Trichomonas vaginalis

0 references

author name string

Kimberle Chapin

series ordinal

1

1 reference

25 August 2017

Sarah Andrea

series ordinal

2

1 reference

25 August 2017

publication date

1 September 2011

1 reference

Expert Review of Molecular Diagnostics: new diagnostic technologies are set to revolutionise healthcare

25 August 2017

published in

1 reference

25 August 2017

volume

11

1 reference

25 August 2017

issue

7

1 reference

25 August 2017

page(s)

679-688

1 reference

ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists, Number 72, May 2006: Vaginitis.

25 August 2017

cites work

1 reference

The prevalence of trichomoniasis in young adults in the United States.

21 January 2018

1 reference

Prevalence and correlates of Trichomonas vaginalis among incarcerated persons assessed using a highly sensitive molecular assay

21 January 2018

1 reference

Prevalence and correlates of Trichomonas vaginalis infection among female US federal prison inmates.

21 January 2018

1 reference

Prevalence of Trichomonas vaginalis infection in women attending a major gynaecological hospital in Greece: a cross-sectional study.

21 January 2018

1 reference

The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

21 January 2018

1 reference

Comparison of APTIMA Trichomonas vaginalis transcription-mediated amplification to wet mount microscopy, culture, and polymerase chain reaction for diagnosis of trichomoniasis in men and women.

21 January 2018

1 reference

Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic

21 January 2018

1 reference

Throwing the dice for the diagnosis of vaginal complaints?

21 January 2018

1 reference

Impact of T. vaginalis infection on innate immune responses and reproductive outcome

21 January 2018

1 reference

The estimated direct medical cost of sexually transmitted diseases among American youth, 2000.

21 January 2018

1 reference

Estimates of the annual number and cost of new HIV infections among women attributable to trichomoniasis in the United States.

21 January 2018

1 reference

Rapid antigen testing compares favorably with transcription-mediated amplification assay for the detection of Trichomonas vaginalis in young women

21 January 2018

1 reference

Diagnosis of Trichomonas vaginalis in adolescent females: InPouch TV culture versus wet-mount microscopy

21 January 2018

1 reference

Evaluation of the OSOM Trichomonas rapid test versus wet preparation examination for detection of Trichomonas vaginalis vaginitis in specimens from women with a low prevalence of infection

21 January 2018

1 reference

Use of an immunochromatographic assay for rapid detection of Trichomonas vaginalis in vaginal specimens

21 January 2018

1 reference

Comparison of Aptima Trichomonas vaginalis transcription-mediated amplification assay and BD affirm VPIII for detection of T. vaginalis in symptomatic women: performance parameters and epidemiological implications

21 January 2018

1 reference

21 January 2018

Update of trichomoniasis

1 reference

Use of an adaptation of a commercially available PCR assay aimed at diagnosis of chlamydia and gonorrhea to detect Trichomonas vaginalis in urogenital specimens

21 January 2018

1 reference

Real-time PCR improves detection of Trichomonas vaginalis infection compared with culture using self-collected vaginal swabs

21 January 2018

1 reference

High analytical sensitivity and low rates of inhibition may contribute to detection of Chlamydia trachomatis in significantly more women by the APTIMA Combo 2 assay

21 January 2018

1 reference

Impact of Trichomonas vaginalis transcription-mediated amplification-based analyte-specific-reagent testing in a metropolitan setting of high sexually transmitted disease prevalence

21 January 2018

1 reference

Screening for Trichomonas vaginalis in high-risk adolescent females with a new transcription-mediated nucleic acid amplification test (NAAT): associations with ethnicity, symptoms, and prior and current STIs.

21 January 2018

1 reference

Epidemiology of sexually transmitted infections in suspected child victims of sexual assault

21 January 2018

1 reference

Trichomoniasis in pregnancy and mental retardation in children

21 January 2018

1 reference

Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with human immunodeficiency virus

21 January 2018

1 reference

Nongonococcal urethritis--a new paradigm

21 January 2018

1 reference

Is Trichomonas vaginalis a cause of cervical neoplasia? Results from a combined analysis of 24 studies.

21 January 2018

1 reference

Association of condom use, sexual behaviors, and sexually transmitted infections with the duration of genital human papillomavirus infection among adolescent women

21 January 2018

1 reference

Prevalence and correlates of bacterial vaginosis among young women of reproductive age in Mysore, India

21 January 2018

1 reference

Innate Immunity and Inflammatory Response to Trichomonas vaginalis and Bacterial Vaginosis: Relationship to HIV Acquisition

21 January 2018

1 reference

Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding

21 January 2018

1 reference

Epidemiology of Trichomonas vaginalis and human papillomavirus infection detected by real-time PCR in flanders

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERM.11.53

1 reference

25 August 2017

1 reference